Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensin...
PharmaEssentia USA Corporation, a subsidiary of Taiwan-based PharmaEssentia Corporation, has announced that th...
Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-gene...
DKSH has signed an agreement to acquire P.R. Chemicals, a specialties distributor of Active Pharmaceutical Ingredients (...
Biopharmaceutical manufacturing is entering a period of significant change. With over 2000 biological therapeutics in de...
Rare diseases/orphan diseases affect a very small fraction of the population and are frequently debilitating. World Heal...
US-based Biohaven and SK Biopharmaceuticals, based in South Korea, have announced a strategic global licensing and ...
Haisco Pharmaceutical Group Co. has entered into an exclusive licensing agreement with Sentivera, a new US venture found...
GC Biopharma, a leading global pharmaceutical company based in South Korea, has announced that its Hunter syndrome treat...
South Korea-based Hanmi Pharm has entered into an exclusive licensing agreement with Genentech, a member of the Roche Gr...
China’s biotech and pharmaceutical sector is entering a new phase of global relevance. A surge in out-licensing de...
Taiwan-based Lotus Pharmaceutical Co. has announced a strategic licensing and commercialisation agreement with Alvotech,...
Genentech, a member of the Roche Group, has announced plans to invest approximately $750 million in a new device fill-fi...
Telix Pharmaceuticals has reported continued progress across its radiopharmaceutical imaging and therapeutic pipeline du...
Japan-based Ono Pharmaceutical has announced that Ono Pharma Taiwan, a Taiwanese subsidiary of Ono, has received the add...
Japan-based Chugai Pharmaceutical has signed an exclusive license agreement with British pharma firm GlaxoSmithKline (GS...
Mankind Pharma, one of India’s leading pharmaceutical companies, has entered into an exclusive in-licensing and ma...
CanSino Biologics has announced that China’s National Medical Products Administration has accepted the New Drug Ap...
LEO Pharma, a global leader in medical dermatology delivering innovative solutions for skin disease, has entered into an...
Everest Medicines has announced that China’s National Medical Products Administration has accepted the Biologics L...
GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved Blenrep for the treatment of...
Shanghai Henlius Biotech has entered into a strategic collaboration with Sandoz, a global leader in generics and bi...
As healthcare systems worldwide seek faster and more effective ways to turn scientific breakthroughs into improved patie...
Asia-Pacific continues to attract investment across pharmaceutical manufacturing, biotechnology, vaccines, advanced ther...
Asia-Pacific is moving from being viewed primarily as a later-stage commercial market to becoming a more important sourc...
